Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 nov. 2025 11h58 HE | Source: Enlivex Therapeutics Ltd

Enlivex mengumumkan Penempatan Persendirian bernilai AS$212,000,000 untuk Memulakan Strategi Perbendaharaan Aset Digital Pasaran Ramalan Pertama di Dunia, melalui Pengumpulan token RAIN, serta Pelantikan Matteo Renzi, Bekas Perdana Menteri Itali, ke dalam Lembaga Pengarahnya

- Selepas penutupan penempatan persendirian, Enlivex akan mengguna pakai strategi perbendaharaan aset digital token pasaran ramalan RAIN pertama di dunia melalui pengumpulan token RAIN. - RAIN ialah...
25 nov. 2025 11h58 HE | Source: Enlivex Therapeutics Ltd

Enlivex Anuncia Colocação Privada de US $212.000.000 para Início da Primeira Estratégia de Previsão de Mercados de Tesouro de Ativos Digitais do Mundo, via Acumulação de tokens RAIN, e a Nomeação de Matteo Renzi, Ex-Primeiro-Ministro da Itália, para seu Conselho

- Após o fechamento da colocação privada, a Enlivex adotará a primeira estratégia de tesouro de ativos digitais de token de previsão RAIN do mundo, por meio do acúmulo de token RAIN. - RAIN é um...
25 nov. 2025 11h58 HE | Source: Enlivex Therapeutics Ltd

Enlivex anuncia una colocación privada de $212,000,000 para iniciar la primera estrategia de tesorería de activos digitales basada en mercados de predicción en el mundo, mediante la acumulación del token RAIN, y el nombramiento de Matteo Renzi, ex Primer Ministro de Italia, como miembro de su directorio.

- Tras el cierre de la colocación privada, Enlivex adoptará la primera estrategia de tesorería de activos digitales basada en mercados de predicción del mundo, mediante la acumulación del token RAIN. ...
25 nov. 2025 11h58 HE | Source: Enlivex Therapeutics Ltd

Enlivex annonce un placement privé de 212 000 000 $ pour lancer la première stratégie au monde de trésorerie d’actifs numériques sur les marchés prédictifs, via l’accumulation de jetons RAIN, et la nomination de Matteo Renzi, ancien Premier ministre italien, à son conseil d’administration

- À la clôture du placement privé, Enlivex adoptera la première stratégie au monde de trésorerie d’actifs numériques sur les marchés prédictifs RAIN, via l’accumulation de jetons RAIN. - RAIN est un...
24 nov. 2025 07h55 HE | Source: Enlivex Therapeutics Ltd

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

- Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. - RAIN is a fully...
24 nov. 2025 06h40 HE | Source: Enlivex Therapeutics Ltd

Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...
28 oct. 2025 08h15 HE | Source: Enlivex Therapeutics Ltd

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025

Ness-Ziona, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that...
02 oct. 2025 13h00 HE | Source: DelveInsight Business Research LLP

CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

New York, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight CRISPR therapies offer...
29 sept. 2025 08h15 HE | Source: Enlivex Therapeutics Ltd

D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex's Knee Osteoarthritis Program

Nes-Ziona, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, will participate in a...
23 sept. 2025 09h47 HE | Source: Precedence Research

Systemic Inflammatory Response Syndrome Treatment Market Size Worth USD 24.76 Billion by 2034 Fueled by Growing ICU Admissions

Ottawa, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The global systemic inflammatory response syndrome treatment market size reached USD 13.85 billion in 2024. It is projected to rise from USD 14.89 billion...

Page précédente

Page suivante